Physician profile
Katherine Black
NPI 1881056646
$982.28
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.48 · 2022: $150 · 2023: $607 · 2024: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $373.80 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $211.58 | 2022-2023 | Dupixent |
| Qol Medical, LLC | $192.58 | 2023-2024 | Sucraid, Sucraid |
| Ipsen Biopharmaceuticals, INC | $69.46 | 2023 | Bylvay |
| Abbvie INC. | $55.90 | 2021-2023 | Humira, Rinvoq |
| Nestle Healthcare Nutrition INC. | $38.93 | 2023 | |
| Acadia Pharmaceuticals INC | $21.32 | 2024 | Daybue |
| Ironwood Pharmaceuticals, INC | $18.71 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Black listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.